Diagnostic Imaging brings you daily coverage of the ECR 2021 virtual annual meeting

ECR 2021: March 3 - March 7, 2021

As technology has advanced, the appearance of medical devices on abdominal X-rays has become more and more common. Knowing what to look for – and recognizing what might be wrong – can play a big role in augmenting a patient’s care.

In a presentation during the 2021 European Congress of Radiology (ECR) annual meeting, D.C. Carvalho, a radiology resident at Centro Hospital Universitário de São João in Portugal, outlined several devices that appear on these images and what you should look out for.

“Failure to recognize [these devices], as well as correct placement or complications can compromised the efficacy of diagnosis,” he said. “The evaluation of abdominal and pelvic devices, as well as their related complications should be an integral part of the study of abdominal X-rays.”

Consequently, when you are reading abdominal X-rays, Carvalho recommended you keep these things in mind:

 The most common complication is misplacement. The ideal position is distal to the gastric cardia, 10 cm caudal to the gastroesophageal junction, he said.

 The most common complication is misplacement that can result in an abnormal peritoneum, such as a perforation.

 This device has three parts: the adjustable gastric band, connector tube, and subcutaneous port. The proper phi angle should be between 4° and 58°. Calculate the angle by drawing a vertical line along the spinal column and a line along the long axis of the band.

 The balloon should be located inside the bladder. If it is visualized below the bladder in the urethra or ureter, it is mispositioned, he said.

 The most common complications are the inadvertent catheterization of the urethra, retained catheter, or encrustation.

 The tip should be in the lower pelvis. An X-ray can be useful in detecting non-infectious complications, such as catheter misplacement, migration, or kinking.

 The tip should be in the renal pelvis, and in the case of the ureteric stent, the other end should be in the bladder. Common complications include migration, encrustation, and stent fracture.

Intrauterine contraceptive devices (IUD)/tubal sterilization devices:

 For an IUD, look for perforation, migration, and fragments. In addition, there are many types of tubal devices, and they are generally horizontal. The distance between the two proximal markers should be less than 4 cm, he said.

 Used to prevent pelvic organ collapse, this device will appear as a large thick ring of uniform density. It should be perpendicular to the plane of the vagina.

 Look for prosthetic fracture, migration, or kinking.

 Keep an eye out for filter tilt – an angle of the filter more than 15° in relation to the device’s long axis – mispositioning, fracture, and migration – the movement of 2 cm or more from its original position.

Look for pneumoperitoneum, stent fracture, migration, misplacement, or collapse.

For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter

Articles

Medical devices are showing up regularly in abdominal X-rays – knowing what to look for and when something might be wrong can help improve diagnosis. 



Medical Devices: What to Look for in Abdominal X-rays

Alleviating a patient’s anxieties over having an imaging study done can sometimes be difficult. The scans are likely unfamiliar, and he or she has likely heard about the risks associated with radiation.

Consequently, it is largely your responsibility to have a clear benefit-risk conversation with both your adult and pediatric patients.

In a presentation during the 2021 European Congress of Radiology annual meeting, Jonathan L. Portelli, Ph.D., a radiography lecturer at L-Università ta’ Malta, outlined several steps you can take to facilitate these discussions. Above all else, he said, remember that each patient encounter will be different.

“We have to acknowledge that every individual is unique, and they will have their own needs, preferences, perceptions, and expectations,” he said. “Having a one-size communication strategy may not actually work – we must think about different considerations.”

To effectively communicate with your adult and pediatric patients about the benefits and risks of imaging, Portelli offered these 10 tips:

 Be sure you have a thorough understanding of the benefits, dose, and risks associated with an imaging procedure so you are in a good position to explain it all confidently to the patient. Your communications should be clear, consistent, and confident, Portelli said.

 These documents should highlight the roles of the various professionals who will be part of the patient’s imaging experience, especially any benefit-risk discussions. You can provide these standards and guidelines in a communication toolkit, FAQ document, quick-reference dose tables, or infographics. Make sure everyone in your office has this information and has been properly trained – everyone should be able to provide the same answers to a patient’s questions.

 Do not walk in to see a patient cold. Familiarize yourself with them and their health history before entering an appointment. Take time to talk with them and show them procedures – videos can be helpful. With children, taking some time to play with them can enhance their cooperation, he said.

 Always greet the patient by name and give him or her your full attention. Introduce yourself, explain your role in their imaging experience, and maintain eye contact. It is important to get on the same level with the patient, especially when dealing with children, Portelli said, and express empathy to everyone associated with the patient.

“A patient may not remember what you said. They may not remember what you did,” he explained. “But, they will not forget how you made them feel.”

 When talking with patients and relatives, use a calm, reassuring tone of voice at all time, and do not rush through a conversation. Offer explanations about exams and their intent without using medical terms or jargon, and walk a patient through what he or she will need to do, as well as what the exam might feel like. Be sure to stop and listen – dialogue is a two-way street, Portelli stressed.

Highlight the exam’s purpose and benefit:

 Explain the importance of the exam and what information it will provide. Above all else, provide the patient with a level of reassurance.

Explain the risks in context of the benefits:

 Patients are frequently nervous, so walk them through the risks while spotlighting the benefits of an exam. Assure them that your staff is trained to minimize risks at every turn. Address any concerns about anesthesia or contrast dye, and help put it all in context.

 Let the patient know the actual risks of the imaging study are likely to be very small compared to the general population, explaining to parents that the risk of cancer from a CT is extremely small in children. Have graphics on-hand to help explain, but avoid using actual numbers, he advised.

“If you tell a parent there is a one in 2,000 risk of cancer, they are just going to think of the situation as being their child and 1,999 others,” Portelli said.

 Do not monopolize the interaction. Ask the patient if he or she has questions or concerns. Watch them closely during your conversation to be sure he or she is satisfied with your explanations or if they are understanding everything correctly.

Enhance the conversation by giving the patient or guardians trusted resources, as well as contact information if future questions rise. Be sure to compliment and thank pediatric patients for being brave and cooperative, he said. In addition, walk a patient through his or her next steps – where will they go, what will they need to do, and how long will they wait for their imaging results.

Following these 10 tips can greatly augment your conversation about imaging benefits and risks with patients, Portelli said.

“Remember your aim is to reassure and help your patient have a positive imaging experience,” he concluded.

With both your adult and pediatric patients, be sure you are doing the best job at explaining both the benefits and risks of imaging studies. 



10 Steps to Better Benefit-Risk Conversations

 Weekly Scan. I’m senior editor Whitney Palmer.

Before we get to our featured interview with Dr. Lynn Baxter, director of breast imaging at Radiology Partners member practice Northside Radiology Associates about how to address COVID-19 vaccine-related adenopathies with patients, here are the top stories of the week.

Missing even one screening mammogram can put a woman at significantly higher risk for dying from breast cancer. According to a study of more than half a million women published in 

, researchers determined that undergoing consecutive mammograms reduces a woman’s risk by half – but, skipping out makes a big difference. From 1992 to 2016, investigators followed 549,091 women in Sweden to see how frequently they underwent screening. During the study, the country’s policy was to offer screening mammography to women ages 40 to 54 every 18 months – it was every 24 months for women ages 55 to 69. The researchers divided women into four groups – those who received two consecutive screenings; those who had their last, but not next-to-last; those who had their next-to-last, but not last; and those who had none. Overall, they identified 3,995 breast cancer deaths across the groups and determined that women who had both screenings had a 49-percent lower risk for breast cancer mortality. It was only 33 percent and 28 percent for women who had only their last or next-to-last screening, respectively. This benefit stretched out for 10 years, they said, with women who underwent both screenings experiencing a 50-percent drop in breast cancer mortality within a decade of the exams.

More radiologists are providing cardiac CT and MRI services, but these studies still are not as common as echocardiography and nuclear medicine, according to a recent study from 

. In a study from 2012 to 2017, investigators examined the number of cardiac CT and MRI exams performed, as well as the number of providers who conducted them. Based on their analysis, they found cardiovascular CT and MRI use rose by 97.4 percent and 75.5 percent, respectively. The number of providers also increased by 84.8 percent for MRI and 77.3 percent for CT. The majority of providers were men, and most were cardiologists or radiologists. However, while reimbursements rates for MRI and CT during the study period amounted to $16.2 million and $55.8 million, respectively, those number paled in comparison to reimbursement for echocardiography and nuclear medicine while came in at $5.9 billion and $4.2 billion, respectively.

This week, Andrew Colbert, senior managing partner and founding member of Ziegler’s Healthcare Investment Banking shared his thoughts on how radiology practices can help secure themselves financially during this turbulent healthcare environment. In his 

, he discussed five factors that are directly impacting the playing field currently: federal healthcare policy changes, industry consolidations and mergers, the push to outpatient service and consumerization, the economic impact of COVID-19, and Medicare payment reallocations. In addition to laying out how each of these factors is making an impact, Colbert pointed to an analysis that could help practices identify areas of investment and fortification, and he highlighted several key types of investments that could drive success.

 spoke with Dr. Lynn Baxter, director of breast imaging at Radiology Partners member practice Northside Radiology Associates about how to address COVID-19 vaccine-related adenopathies with patients. Not only did she discuss how both technologists and radiologists should approach this information with patients, but she shared how her practice, in particular, does it. Here’s what she said.

Videos

Dangers of missing one screening mammogram; Rise of cardiac CT and MRI; Strategies to improve financial stability; Plus, Talking to patient about COVID-19 vaccine-related adenopathies.

Diagnostic Imaging's Weekly Scan: March 1, 2021, to March 5, 2021

Using automated machine learning to calculate the right ventricle/left ventricle (RV/LV) ratio can help radiologists identify patients who have pulmonary hypertension (PH) and would benefit from being referred to a specialist.

In a presentation during the 2021 European Congress of Radiology annual meeting, Pia Charters from Royal United Hospital Bath NHS Foundation Trust outlined the results of a study that examined the efficacy and feasibility of using this automated analysis to better predict PH in patients who receive indeterminate results with transthoracic echocardiogram (TTE).

While TTE is the typical screening method used to detect PH, it has poor agreement with right heart catheter (RHC) gold standard, she noted. Consequently, there is a need for a better assess patients who receive unclear TTE results.

Charters’ team conducted a retrospective study with 241 patients who underwent RHC between June 2017 and March 2018. They also had either CTPA or TTE within the previous 12 months. The team used measurements decided by both the European Society of Cardiology (ESC) and the World Symposium of PH (WSPH) to identify patients with PH. Individuals were considered to have PH by the RHC gold standard if their mPAP was greater than or equal to 25 mmHg (ESC) or between 20-24 mmHg with pulmonary vascular resistance greater than 3 (WSPH).

Based on their analysis, the team determined that 179 patients met the ESR definition, and 181 satisfied the WSPH definition. Patients with PH tended to be older with a median age of 67 and female, Charters said.

In addition, the team identified a mean automated RV/LV for ESC and WSPH PH of 1.37 and a mean automated RV/LV for mPAP <20 mmHg of 1.09. There was a significant, strong relationship between the RV/LV ratio and mPAP and the RV/LV ratio and PVR, she said.

Their results also revealed that automated RV/LV had high diagnostic accuracy for detecting PH with the area under the curve of 0.796. Also, RV/LV >0.935 was more sensitive in detecting both ESC and WSPH PH than TTE or a manual pulmonary ratio.

Overall, Charters said, the automated RV/LV threshold has high sensitivity for both ESC- and WSPH-defined PH, and it offer diagnostic utility when patient’s return with an indeterminate TTE score. Not only does the ratio correlate with mPAP and PVR, but the analysis can also be used to increase or decrease the pre-test probability of those patients. There is also the possibility that it could change the impact of screening.

“There is the potential to screen all patients undergoing CTPA for PH, identifying them radiologically as opposed to clinically, with emphasis on early detection and earlier intervention,” she said.

For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter 

An automated approach can be useful with patients who have indeterminate transthoracic echocardiograms.

Machine Learning with Contrast-Enhanced CT Can Help Identify Pulmonary Hypertension

Konica Minolta Health Americas unveiled its new X-ray system – AeroDR X90 – this week during the European Congress of Radiology (ECR) 2021.

The ergonomically designed system uses auto-positioning, auto-tracking, and auto-stitching to facilitate more efficient workflow. By including auto-stitching, the system can truncate patient hold time and accelerate daily workflow. Up to four images, which are obtained by pressing the X-ray button, can be stitched together to create a long leg and full spine examination.

In addition, the detector can automatically move into correctly defined position when the patient is placed on the stitching trolley.

Konica Minolta releases new system during annual meeting.

AeroDR X90 X-ray Debuts at ECR 2021

When it comes to breast imaging, there are many techniques and strategies available to pinpointing and assessing lesions. In a session during the 2021 European Congress of Radiology annual meeting, a group of international experts offered their top three tips for complex cystic and solid lesions, contrast-enhanced spectral mammography, stereotactic-guided biopsy, ultrasound-guided biopsy, and MRI-guided biopsy.

Take a quick look at the guidance they offered: 

Breast Imaging: Three Top Tips

Slideshows

Experts at ECR 2021 offer their top three tips for a variety of breast imaging techniques.

ECR 2021: Top Three Tips for Breast Imaging

Hitachi Medical Systems launched two new permanent open MRI systems at the start of the 2021 European Congress of Radiology. Both systems are equipped with SynergyDrive workflow solution.

Hitachi unveiled its first permanent open MRI system in 1996, but these two new systems are designed with lower field strength. They are also offer automated – and faster – image capture, according to a company statement.

Hitachi Medical System's APERTO Lucent Plus

Credit: Hitachi Medical Systems Europe Holding AG /news aktuell via AP Images

Hitachi Medical System's AIRIS Vento Plus

Both the APERTO Lucent Plus, a 0.4T permanent open MRI, and the AIRIS Vento Plus, a 0.3T permanent open MRI, provide high-speed exams with motion-free images, as well as easy siting and operation for fast return-of-image and an open design that maximizes patient comfort. In addition, they also share three main features:

This high-speed feature shortens scan times without loss of image quality, and it combines under-sampling and image reconstruction via iterative image processing to perform T1-weighted, T2-weighted, STIR, FLAIR, MRA, diffusion-weighted, and fat-water separation images.

By pre-defining scan condition settings, such as slice positioning, image processing, image display, and image transfer, this feature offers single-click exams. According to the company statement, it can automatically propose the optimum slice plane on the brain immediately after the scanogram, and up to five slice planes can be preset for slice plane and angle. With an AutoClip function, it automatically depicts the region of interest of the brain MRA.

 By combining IP-RAPID and AutoExam, this feature improves operability, the company said, and can reduce scan times by up to 30 percent compared to Hitachi’s conventional open MRI systems.

Two new permanent MRI systems are designed to streamline workflow and truncate scan time by roughly one-third.

Hitachi Launches New Open MRI Systems at ECR 2021

Case submitted by Mohammad Osama Yonso M.D.

A 17-year-old male presented for evaluation of scoliosis. His physical exam showed high riding medially rotated scapula with similar findings demonstrated on chest radiograph.

Sprengel deformity is a rare disorder, congenital variant, in which the scapula is high riding on one side of the body. The affected abnormal scapula is also connected to spine abnormally, often restricting movement of the shoulder.

What is your diagnosis in this patient who presents for evaluation of scoliosis?

Image IQ Quiz: Patient Presents for an Evaluation of Scoliosis

A hybrid artificial intelligence (AI) approach that combines both machine (ML) and deep learning (DL) can predict the severity of a patient’s case of COVID-19 by using both clinical data and chest X-rays, say researchers from Italy.

Investigators presented their findings – and announced their open-access database – during the European Congress of Radiology (ECR) 2021 annual meeting.

By using 820 chest X-rays and clinical data, including demographics, blood analysis, oxygen saturation, and co-morbidities, collected from six hospitals and two research institutions in Italy, the team was able to predict – with accuracy, as well as high sensitivity and specificity – which patients would have more severe disease, said presenter Marco Alì, Ph.D., a fellow in integrated biomedical research from Centro Diagnostico Italiano.

The team defined patients with mild disease as those who were sent home to recover or who were hospitalized without ventilation. Patients with severe disease were hospitalized with ventilation, treated in the intensive care unit, or they died.

The team compared their chest X-ray/clinical data ML-DL hybrid model to strategies that applied ML and DL only to clinical data or only to chest X-rays. According to their analysis, their hybrid model performed the best with 77 percent accuracy, 79 percent sensitivity, and 75 percent specificity.

When they drilled down into the data, they determined that 87 percent of patients had at least one co-morbidity with hypertension being the most common, affecting 45 percent of patients overall. Specifically, among patients who experienced severe COVID-19, 27.9 percent had hypertension, and 21 percent had pre-existing cardiovascular disease.

In addition, Alì said, men were more likely to suffer severe disease. They accounted for 72 percent of deaths.

The images used to test this hybrid strategy can be found 

Combining machine learning and deep learning with clinical data and chest X-rays can point to either mild or severe disease.

ECR 2021: A Hybrid AI Approach to Predicting COVID-19 Severity

When it comes to breast cancer screening for women with dense breasts, automated breast ultrasound (ABUS) is the right choice to supplement mammography, according to industry experts.

During a 2021 European Congress of Radiology (ECR) annual meeting presentation, Athina Vourtsis, M.D., Ph.D., director of the Diagnostic Mammography Center in Athens, Greece, as well as the founding president of the Hellenic Breast Imaging Society, made the case for using ABUS whenever you need additional screening for women who have greater breast density.

While screening mammography is still considered the gold standard for breast cancer detection, she noted that 50 percent of existing breast cancers are not associated with the micro-calcifications mammography picks up best. That opens the door for the masking effect, leading to a potential rise in interval cancers.

In addition, 43 percent of women between ages 40 and 74 have dense breasts. Not only are they four-to-six times more likely to develop breast cancer, but they also face an 18-times higher risk of an interval cancer. Consequently, Vourtsis said, implementing an effective supplemental screening tool is critical.

Hand-held ultrasound (HHUS) can work well, she said, but it does present challenges. Capturing high-quality images can require rigorous training, and it still depends on operator experience. The field-of-view is also small, and HHUS does have a higher false positive rate.

This is where ABUS comes in, she said. It can be used in diagnostic settings, as a second look after MRI, in pre-operative settings, or it can be used for the correlation of molecular subtypes of breast cancer.

Among several benefits, Vourtsis said, ABUS is operator-independent, offers a larger field-of-view, can complete both batch and double reading, and it can integrate computer aided detection (CAD).

The images produced are superior, as well, she explained, as the tool can convert 2D datasets into multi-planar 3D reconstructed images that give radiologists a more thorough view of the breast. According to existing research, she said, this multi-planar reconstruction offers 96 percent-to-100 percent specificity and 80 percent-to-89 percent sensitivity for breast cancer detection, as well as an improved area under the curve. Additionally, evidence shows that it can downgrade between 3 percent and 18 percent of benign biopsied lesions to BI-RADS 2.

There are three aspects to successful ABUS implementation, Vourtsis said, with the technologist, patient, and radiologist all playing significant roles.

The technologist is responsible for appropriately positioning the patient and applying enough lotion to the entire breast prior to imaging. Adequate depth and compression, as well as proper transducer positioning are vital to getting the best images. Following these steps will result in optimal image capture that can do a better job of detecting smaller breast cancers that are behind the nipple, near the chest wall, or in the periphery of the breast. It can also decrease the false positive rate and improve the positive predictive value of the biopsies performed.

Instruct each patient to continue to breath normally, but to avoid speaking or coughing during the imaging process. They should also remain still and not try to change positions between each image acquisition.

In order to decrease the false positive rate, providers must capture precise information from the patient’s history. Be sure to read all volumes and planes, she recommended, and in the radiology report, use BI-RADS structured reporting and record all findings. You should also read both ABUS and mammography images for the most complete assessment.

Radiologists also need proper training and education in order to be able to identify the artifacts that can occur with ABUS, Vourtsis stressed.

There are four main types of artifacts you can encounter:

Technical: Caused by improper positioning, lack of contact, or skin folds.

Software: A result of nipple artifact or silhouette.

Physiologic: Caused by cardiac activity or motion.

Lesion-related: A result of skip, enhancement, or shadowing.

There are ways to avoid these artifacts, however, she said:

Use additional planes to analyze peripheral abnormalities and artifacts.

Use a second view to resolve shadowing as a one-view-only artifact.

Use the rotational software to interpret shadowing.

Even with all these benefits and capabilities, Vourtsis said, work is still ongoing to continue to improve ABUS. Research is currently underway to see how implementing CAD could drive down the recall rate associated with the screening method while improving the detection of suspicious lesions.

For women with dense breasts, automated breast ultrasound offers advantages over supplemental screening with hand-held ultrasound. 

ECR 2021: ABUS as the Right Follow-up to Screening Women with Dense Breasts

ControlRad, Inc., announced this week it has secured U.S. Food & Drug Administrationg 510(k) clearance for its ControlRad Select system designed to reduce unnecessary radiation exposure during fluoroscopically guided procedures.

This technology, which uses proprietary semi-transparent filters, a user-interface tablet, and image processing algorithms, retrofitted onto existint Siemens Artis zee interventional imaging systems, can reduce radiation dose by 85 percent for images captured in cath, interventional radiology, and electrophysiology labs, said ControlRad CEO Guillaume Bailliard.

ControlRad, Inc., technology will now be available on Siemens’ interventional imaging systems.

Radiation Dose Reduction Company Wins FDA Clearance

Shear wave elastography can outperform MRI in pinpointing whether any malignant tissue has been left behind after brain surgery.

While MRI is currently considered the gold standard for determining whether a patient might have a relapse after having a brain tumor surgically removed, it is both costly and time-consuming, sometimes adding up to two additional hours to a procedure. In a new study published in 

a multi-institutional team discovered shear wave elastography was a much more sensitive technique.

The team, led by Jeffrey Bamber, Ph.D., professor of physics applied to medicine at The Institute of Cancer Research in London, compared shear wave scans to standard 2D ultrasound and a surgeon’s opinion. They, then, compared those results to MRI outcomes.

“We have shown for the first time that this new tool is better than either a standard 2D ultrasound or a surgeon’s judgment on its own,” Bamber said, “and has the potential to supplement a surgeon’s opinion as a means of improving outcomes from operations.”

This study, the team said, is the first to unearth shear wave’s real-time efficacy as a neurosurgical tool that can be used during procedures for cancerous tissue identification. Because brain tumor tissue tends to be stiffer than normal brain tissue, shear wave elastography is to optimal technique for identifying tissue that still needs to be removed, they added.

In a study with 26 patients, the team performed shear wave and 2D ultrasound before, during, and after the tumor removal. In addition, prior to showing surgeons any images, they asked surgeons to assess whether any malignant tissue remained. To get a clear idea of performance, the team also compared results to post-surgery MRI scans.

Based on their analysis, shear wave elastography was more sensitive in pinpointing residual tumor tissue than either standard ultrasound or surgeon opinion – it offered 94-percent sensitivity compared to 73 percent with standard ultrasound and 36 percent with the surgeon. With this performance, Barber said, shear wave was 2.5 times more likely to pick up remaining malignant tissue than a surgeon.

But, the technique’s specificity was only middle of the road, he explained. It offered 77-percent specificity, compared with 63 percent with standard ultrasound and 100 percent for surgeons. What that translates into is, given shear wave’s propensity for more false positives, it could be best used in concert with a surgeon’s professional analysis.

“This technique provides a very practical means of detecting areas of potentially removable tumor that are not readily visible to the operating surgeon,” said Neil Dorward, MB, BSc, a consultant neurosurgeon and co-researcher at the National Hospital for Neurology and Neurosurgery. “The surgeon must use his or her experience to decide whether the area of abnormality should be resected. This has the potential to substantially improve the outcome of such operation.”

While these results are encouraging and could potentially improve patient outcomes, the team said, additional, larger studies are needed to validate whether shear wave elastography can be offered as a standard practice.

Compared with three other methods, shear wave elastography providers greater sensitivity in pinpointing remaining malignant tissue after brain tumor removal.



Shear Wave Elastography Better than MRI, Surgeons at Detecting Residual Brain Tumor Tissue

Medical artificial intelligence (AI) start-up Lunit announced, during the 2021 European Congress of Radiology (ECR) annual meeting, that its AI software will now be available on Philips Healthcare’s diagnostic X-ray solutions.

This move marks the latest extension of Philips’ AI portfolio in precision diagnosis. It is designed to improve patient outcomes and experience, according to a company statement.

Lunit INSIGHT CXR detects findings and provides abnormality score on a chest X-ray image

Lunit INSIGHT CXR chest detection suite can identify 10 of the most common findings on chest X-rays by mapping finding locations and displaying a scored calculation of where those findings actually are. By using abnormality scores, the software prioritizes scans, allowing for faster triage of the most critical images.

Based on existing publications, including studies in 

 the algorithm can perform with 97 percent to 99 percent accuracy.

This collaboration will potentially accelerate the diagnostic capabilities of facilities, said Daan van Manen, general manager for diagnostic X-ray at Philips.

“Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact,” Manen said. “Our partnership with Lunit to incorporate their diagnostic AI into our X-ray platform combines with a host of smart workflow features in the Philips Eleva user interface, our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow.”

Lunit INSIGHT CXR is already CE marked and clinically available in Europe, Middle East, Latin America, South East Asia, Australia, and New Zealand. The company expects U.S. Food & Drug Administration clearance this year.

Lunit’s INSIGHT CXR software will be available on Philips’ X-ray solutions.

Radiation Dose Reduction Company Wins FDA Clearance

Shear Wave Elastography Better than MRI, Surgeons at Detecting Residual Brain Tumor Tissue

Lunit Partners with Philips on Chest X-ray AI Solution